8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934

March 16, 2007

Date of report (Date of earliest event reported)

Cyanotech Corporation

(Exact name of registrant as specified in its charter)

NEVADA 000-14602 91-1206026

(State or other jurisdiction of (Commission File Number) (IRS Employer Identification incorporation) Number)

73-4460 Queen Kaahumanu Highway, Suite #102, Kailua Kona, HI 96740

(Address of principal executive offices)

(808) 326-1353

(Registrant’s telephone number)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

(a)  On March 14, 2007, the Company was notified by the Nasdaq Listing Qualifications Panel that it has demonstrated compliance with all Nasdaq Marketplace Rules.  Accordingly, Nasdaq determined to continue the listing of the Company’s securities on The Nasdaq Stock Market.

Item  5.03. —Amendments to Articles of Incorporation

The Form 8-K filed by Cyanotech Corporation on October 18, 2006, and dated October 16, 2006, is incorporated herein by reference, and there is filed herewith as Exhibit 3.1 the Certificate of Change referred to therein.

Item 8.01 — Other Events

On March 16, 2007, the Company issued a news release announcing that it had filed on March 14, 2007 its Form 10-Q for the quarter ended December 31,  2006. In the same release it also announced the continued listing of its Common Stock on the Nasdaq Stock Market. See Item 3.01 herein. The news release is attached hereto as Exhibit 99.1.

(d) Exhibits:

Exhibit Number
3.1	Certificate of Change Pursuant to Nevada Revised Statutes (NRS)
99.1	News Release Headed: Cyanotech Receives Notice of Compliance from Nasdaq

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CYANOTECH
	CORPORATION (Registrant)
March 20, 2006	By:	/s/ William R. Maris
		William R. Maris
		Chief Financial Officer
		and VP of Finance and Administration

2

EX-3.1

Exhibit 3.1

[LOGO]	DEAN HELLER		Enitity #
	Secretary of State		C1188-1980
	206 North Carson Street, Suit 1		Document number
	Carson City, Nevada 89701-4298		20060658247
	(775) 884 5708
	Website: secretaryofstate.biz		Dated Filed:
			10/13/2006 11:06:3
			In the office of
Certificate of Change Pursuant			/s/ Dean Heller
To NRS 78.209
			Dean Heller
			Secretary of State
		ABOVE SPACE IS FOR OFFICE USE ONLY

Certificate of Change filed Pursuant to NRS 78.209

For Nevada Profit Corporations

1. Name corporation:

Cyanotech CORPORATION

2. The board of directors have adopted a resolution pursuant to NRS 78.207 and have obtained any required approval of the stockholders.

3. The current number of authorized shares and the per value, if any, of each class or series, if any, of shares before the change:

30,000,000 $0.005 Par Value Common Stock Shares, and 5,000,000 $0.01 Par Value Preferred Stock Share,

4. The number of authorized shares and the par value, if any, of each class or series, if any, of shares after the change:

7,500,000 $0.02 Par Value Common Stock Shares, and 5,000,000 $0.01 Par Value Preferred Stock Shares

5. The number of shares of each affected class or series, if any, to be issued after the change in exchange for each issued share of the same class or series:

One Share of $0.02 Par Value Common Stock in exchange for each four shares of $0.005 Par Value Common Stock

6. The provisions, if any, for the issuance of fractional shares, or for the payment of money or the issuances of scrip to stockholders otherwise entitled to a fraction of a share and the percentage of outstanding shares affected thereby:

The Company will pay cash for fractional Common Stock Shares. Approximately 1% or less will be so affected thereby.

7. Effective date of filing (optional): 11/3/06

8. Officer Signature:	/s/ William R. Maris	Secretary
	Signature	Title

IMPORTANT: Failure to include any of the above information and submit the proper fees may cause this filing to be rejected.

This form must be accompanied by appropriate fees.

EX-99.1

Exhibit 99.1

News Release	Contact:	Bruce Russell
		Russell Communications Group
		310-559-4955 x101
		brucerussell@ruscom.com

Cyanotech Receives Notice of Compliance from Nasdaq

KAILUA-KONA, Hawaii (March 16, 2007) — Cyanotech Corporation (Nasdaq: CYAN) filed with the Securities and Exchange Commission on March 14, 2007 its Form 10-Q for the quarter ended December 31, 2006.  Therefore, the Company is in compliance with SEC periodic report requirements.  On the same date, the Company was notified by the Nasdaq Listing Qualifications Panel that it has demonstrated compliance with all Nasdaq Marketplace Rules.  Accordingly, Nasdaq determined to continue the listing of the Company’s securities on The Nasdaq Stock Market.

Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that enhance human health and nutrition. Cyanotech’s spirulina, FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use as a food ingredient, augments energy and immune response. BioAstin’s benefits derive from its superior antioxidant activity and from its ability to support and maintain natural inflammatory response, enhancing skin, muscle and joint health.  NatuRose® Natural Astaxanthin is a natural pigment source that also promotes animal health and nutrition, primarily in aquaculture. Phycobiliproteins are fluorescent pigments used in medical diagnostic testing and research. Cyanotech produces these products from microalgae grown at its 90-acre facility in Hawaii using patented and proprietary technology and distributes them to nutritional supplement, nutraceutical, cosmeceutical, and animal feed makers and marketers in more than 40 countries worldwide. Cyanotech was the first microalgae company in the world to obtain ISO 9001:2000. Visit www.cyanotech.com for more information.

#   #   #

73-4460 Queen Kaahumanu Highway, #102  ~  Kailua-Kona, Hawaii 96740

(808) 326-1353  fax (808) 329-3597  ~ www.cyanotech.com